← Leaderboards
Barbara J Mason
Scripps Research Institute, The
$35,175,467
Attributed
$35,175,467
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$55,663,273 · 22
By mechanism
R01$20,225,328 · 5
P60$19,655,610 · 7
R37$6,090,259 · 1
P20$5,154,447 · 3
U01$2,615,709 · 1
R21$970,423 · 2
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Matthew Wallace Buczynski$2,565,863
- Patricia Helen McDonald$7,016,849
Others in their field
Top investigators on “Abstinence”
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$37,092,310
- Robert M. Grant · J. David Gladstone Institutes$36,697,634
- T John Winhusen · University Of Cincinnati$34,347,789
- Stephen T Higgins · University Of Vermont &St Agric College$34,051,568
- Kenneth Silverman · Johns Hopkins University$30,748,980
- Rebecca D Jackson · Ohio State University$29,698,788
Research focus
AbstinencePharmaceutical PreparationsCravingRelapseNeurobiologyWithdrawalStressDrinkingLaboratoriesAnimal ModelBrainFundingDesignPlacebosAlcoholsAddictionResearch PersonnelDouble-Blind MethodAlcohol Use DisorderAnxietyGabapentinAlcoholismPre-ClinicalPrograms
Grant awards (98)
CNS Effects of Alcohol: Cellular Neurobiology$1,830,941
P60 · FY2024 · AA · contact PI
Administrative Core$202,696
P60 · FY2024 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,834,175
P60 · FY2023 · AA · contact PI
Administrative Core$187,036
P60 · FY2023 · AA · contact PI
Administrative Core$99,981
P60 · FY2023 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$99,981
P60 · FY2023 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,809,355
P60 · FY2022 · AA · contact PI
Clinical Component - Mason$261,227
P60 · FY2022 · AA · contact PI
ARC Administrative Core$146,218
P60 · FY2022 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,809,355
P60 · FY2021 · AA · contact PI
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune$522,391
U01 · FY2021 · AA · contact PI
Clinical Component - Mason$261,225
P60 · FY2021 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$248,500
P60 · FY2021 · AA · contact PI
Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency$210,781
R21 · FY2021 · AA · contact PI
ARC Administrative Core$146,220
P60 · FY2021 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,809,355
P60 · FY2020 · AA · contact PI
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune$522,391
U01 · FY2020 · AA · contact PI
Clinical Component - Mason$261,226
P60 · FY2020 · AA · contact PI
Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency$255,156
R21 · FY2020 · AA · contact PI
ARC Administrative Core$146,218
P60 · FY2020 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,809,355
P60 · FY2019 · AA · contact PI
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune$522,391
U01 · FY2019 · AA · contact PI
Clinical Component - Mason$261,227
P60 · FY2019 · AA · contact PI
ARC Administrative Core$146,217
P60 · FY2019 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,809,355
P60 · FY2018 · AA · contact PI
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder$608,854
R01 · FY2018 · AA · contact PI
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune$522,391
U01 · FY2018 · AA · contact PI
Clinical Component - Mason$261,227
P60 · FY2018 · AA · contact PI
ARC Administrative Core$146,218
P60 · FY2018 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,798,217
P60 · FY2017 · AA · contact PI
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder$576,202
R01 · FY2017 · AA · contact PI
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune$526,145
U01 · FY2017 · AA · contact PI
Education Component$100,197
P60 · FY2017 · AA · contact PI
Administrative Core$78,888
P60 · FY2017 · AA · contact PI
CNS Effects of Alcohol: Cellular Neurobiology$1,798,217
P60 · FY2016 · AA · contact PI
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder$573,225
R01 · FY2016 · AA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$188,553
R01 · FY2016 · AA · contact PI
Pilot Component$113,700
P60 · FY2016 · AA · contact PI
Education Component$100,200
P60 · FY2016 · AA · contact PI
Administrative Core$78,883
P60 · FY2016 · AA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$717,873
R01 · FY2015 · AA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$659,778
R01 · FY2015 · DA · contact PI
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder$547,361
R01 · FY2015 · AA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$188,553
R01 · FY2015 · AA · contact PI
Recent Frontiers and Advances in Drug Addiction (IDARS Conference)$45,000
R13 · FY2015 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$717,875
R01 · FY2014 · AA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$592,484
R01 · FY2014 · DA · contact PI
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder$566,683
R01 · FY2014 · AA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$94,752
R01 · FY2014 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$688,268
R01 · FY2013 · AA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$573,528
R01 · FY2013 · DA · contact PI
Gabapentin Treatment of Cannabis Dependence$550,473
R01 · FY2013 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$740,077
R01 · FY2012 · AA · contact PI
Gabapentin Treatment of Cannabis Dependence$670,072
R01 · FY2012 · DA · contact PI
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence$544,193
R37 · FY2012 · AA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$827,776
R01 · FY2011 · AA · contact PI
Gabapentin Treatment of Cannabis Dependence$716,618
R01 · FY2011 · DA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$601,174
R01 · FY2011 · DA · contact PI
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence$544,449
R37 · FY2011 · AA · contact PI
TRANSLATIONAL CTR ON THE CLINICAL NEUROBIOL OF CANNABIS ADDICTION$957,255
P20 · FY2010 · DA · contact PI
Gabapentin Treatment of Cannabis Dependence$673,723
R01 · FY2010 · DA · contact PI
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence$625,857
R37 · FY2010 · AA · contact PI
Pharmacological Treatment of Cannabis Withdrawal and Dependence$612,325
R01 · FY2010 · DA · contact PI
CLIN & NEUROBIOL EFFECTS OF CANNABIS DEPENDENCE IN YOUNG ADULTS$216,239
P20 · FY2010 · DA · contact PI
ADMINISTRATIVE AND SCIENTIFIC SUPPORT CORE$80,235
P20 · FY2010 · DA · contact PI
TRANSLATIONAL CTR ON THE CLINICAL NEUROBIOL OF CANNABIS ADDICTION$925,920
P20 · FY2009 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$834,812
R01 · FY2009 · AA · contact PI
Gabapentin Treatment of Cannabis Dependence$712,140
R01 · FY2009 · DA · contact PI
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence$537,518
R37 · FY2009 · AA · contact PI
CLIN & NEUROBIOL EFFECTS OF CANNABIS DEPENDENCE IN YOUNG ADULTS$210,051
P20 · FY2009 · DA · contact PI
ADMINISTRATIVE AND SCIENTIFIC SUPPORT CORE$78,603
P20 · FY2009 · DA · contact PI
TRANSLATIONAL CTR ON THE CLINICAL NEUROBIOL OF CANNABIS ADDICTION$942,921
P20 · FY2008 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$810,499
R01 · FY2008 · AA · contact PI
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence$601,297
R37 · FY2008 · AA · contact PI
CLIN & NEUROBIOL EFFECTS OF CANNABIS DEPENDENCE IN YOUNG ADULTS$214,686
P20 · FY2008 · DA · contact PI
ADMINISTRATIVE AND SCIENTIFIC SUPPORT CORE$76,908
P20 · FY2008 · DA · contact PI
TRANSLATIONAL CTR ON THE CLINICAL NEUROBIOL OF CANNABIS ADDICTION$1,004,904
P20 · FY2007 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$787,699
R01 · FY2007 · AA · contact PI
Gabapentin Treatment of Alcohol Dependence$594,971
R37 · FY2007 · AA · contact PI
ADMINISTRATIVE AND SCIENTIFIC SUPPORT CORE$228,367
P20 · FY2007 · DA · contact PI
Gabapentin for Cannabis Withdrawal and Use$225,636
R21 · FY2007 · DA · contact PI
CLINICAL AND NEUROBIOLOGICAL EFFECTS OF CANNABIS DEPENDENCE IN YOUNG ADULTS$218,358
P20 · FY2007 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$789,225
R01 · FY2006 · AA · contact PI
Gabapentin Treatment of Alcohol Dependence$667,103
R37 · FY2006 · AA · contact PI
Gabapentin for Cannabis Withdrawal and Use$278,850
R21 · FY2006 · DA · contact PI
Medication Development for Protracted Abstinence in Alcoholism$818,653
R01 · FY2005 · AA
Gabapentin Treatment of Alcohol Dependence$669,507
R37 · FY2005 · AA
Gabapentin Treatment of Alcohol Dependence$656,259
R37 · FY2004 · AA
Naltrexone in nicotine and alcohol dependence$30,227
M01 · FY2004 · RR
MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO$726,516
R01 · FY2003 · AA
Gabapentin Treatment of Alcohol Dependence$649,105
R37 · FY2003 · AA
MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO$526,975
R01 · FY2002 · AA
MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO$611,327
R01 · FY2001 · AA
BEHAVIORAL/PHARMACOLOGIC TREATMENT OF ALCOHOLISM$438,135
U10 · FY2001 · AA
MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO$496,434
R01 · FY2000 · AA
BEHAVIORAL/PHARMACOLOGIC TREATMENT OF ALCOHOLISM$438,135
U10 · FY2000 · AA
NALMEFENE IN NICOTINE AND ALCOHOL DEPENDENCE$239,614
R01 · FY2000 · AA
NALMEFENE IN NICOTINE AND ALCOHOL DEPENDENCE$185,207
R01 · FY2000 · AA